Lanzhou Foci Pharmaceutical Co.,Ltd.’s Net Profit Rose 13.3% in 2022

Lanzhou Foci Pharmaceutical Co.,Ltd. (兰州佛慈制药股份有限公司) (002644.SZ) reported a net profit of 105.9 million yuan in 2022, up 13.3% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 24.6% year-on-year.

At the end of the reporting period, it had 2.6 billion yuan in total assets and 852.6 million yuan in total liabilities, with a liability-to-asset ratio of 33%.